4//SEC Filing
Schilke Tobin 4
Accession 0001479290-23-000077
CIK 0001479290other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 6:06 PM ET
Size
6.1 KB
Accession
0001479290-23-000077
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2023-06-01$30.57/sh−2,701$82,570→ 81,328 total - Sale
Common Stock
2023-06-02$31.00/sh−500$15,500→ 80,828 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan dated November 18, 2022 by Mr. Schilke.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001678984
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 6:06 PM ET
- Size
- 6.1 KB